42.11
price up icon3.45%   1.49
 
loading
前日終値:
$40.62
開ける:
$41.66
24時間の取引高:
2.35M
Relative Volume:
1.13
時価総額:
$5.22B
収益:
$692.26M
当期純損益:
$-512.41M
株価収益率:
-9.9316
EPS:
-4.24
ネットキャッシュフロー:
$-274.36M
1週間 パフォーマンス:
+10.58%
1か月 パフォーマンス:
-10.31%
6か月 パフォーマンス:
+18.30%
1年 パフォーマンス:
+55.05%
1日の値動き範囲:
Value
$39.70
$42.52
1週間の範囲:
Value
$37.73
$42.52
52週間の値動き範囲:
Value
$20.14
$52.92

Guardant Health Inc Stock (GH) Company Profile

Name
名前
Guardant Health Inc
Name
セクター
Healthcare (1175)
Name
電話
855-698-8887
Name
住所
3100 HANOVER STREET, PALO ALTO
Name
職員
2,021
Name
Twitter
@guardanthealth
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
GH's Discussions on Twitter

GH を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Diagnostics & Research icon
GH
Guardant Health Inc
42.10 4.85B 692.26M -512.41M -274.36M -4.24
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
396.20 152.34B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
188.97 135.39B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
514.85 41.54B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
110.86 31.59B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
138.83 24.31B 15.50B 1.33B 2.16B 7.34

Guardant Health Inc Stock (GH) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-10 開始されました Mizuho Outperform
2025-01-23 開始されました Barclays Overweight
2024-06-28 アップグレード Guggenheim Neutral → Buy
2024-06-03 再開されました Jefferies Buy
2024-04-24 再開されました Craig Hallum Buy
2023-12-14 開始されました Guggenheim Neutral
2023-12-13 開始されました Wolfe Research Peer Perform
2023-11-13 アップグレード Raymond James Mkt Perform → Outperform
2023-09-28 開始されました Bernstein Outperform
2023-09-27 アップグレード Piper Sandler Neutral → Overweight
2023-07-05 再開されました JP Morgan Overweight
2023-05-26 アップグレード Citigroup Neutral → Buy
2023-05-05 開始されました UBS Buy
2023-03-09 ダウングレード Citigroup Buy → Neutral
2023-01-05 開始されました Scotiabank Sector Outperform
2022-11-01 ダウングレード Piper Sandler Overweight → Neutral
2022-10-19 開始されました Craig Hallum Buy
2022-10-06 開始されました Stephens Overweight
2022-08-25 開始されました Credit Suisse Outperform
2022-06-03 開始されました Piper Sandler Overweight
2022-04-28 再開されました BTIG Research Buy
2022-02-24 繰り返されました Canaccord Genuity Buy
2022-02-24 繰り返されました Citigroup Buy
2022-02-24 繰り返されました Cowen Outperform
2022-02-24 繰り返されました Morgan Stanley Overweight
2022-02-24 繰り返されました SVB Leerink Outperform
2022-02-24 繰り返されました Stifel Buy
2022-02-24 繰り返されました Wells Fargo Overweight
2021-10-15 再開されました Cowen Outperform
2021-06-15 開始されました Raymond James Mkt Perform
2021-06-03 開始されました Goldman Buy
2021-05-25 開始されました Wells Fargo Overweight
2021-01-11 開始されました Stifel Buy
2020-09-09 開始されました Morgan Stanley Overweight
2020-06-12 開始されました BTIG Research Buy
2020-02-21 開始されました Guggenheim Buy
2020-01-07 開始されました Citigroup Buy
2019-08-07 繰り返されました Canaccord Genuity Buy
2019-04-16 開始されました Canaccord Genuity Buy
2019-04-10 アップグレード BofA/Merrill Neutral → Buy
2019-02-28 繰り返されました BofA/Merrill Neutral
2018-10-29 開始されました BofA/Merrill Neutral
2018-10-29 開始されました JP Morgan Overweight
2018-10-29 開始されました William Blair Outperform
すべてを表示

Guardant Health Inc (GH) 最新ニュース

pulisher
11:25 AM

Raymond James reaffirms Guardant Health stock rating after NCCN update - Investing.com Australia

11:25 AM
pulisher
10:30 AM

National Comprehensive Cancer Network (NCCN) Updates Colorectal Cancer Screening Guidelines to Include Shield Blood-Based Screening - BioSpace

10:30 AM
pulisher
08:53 AM

Guardant Health (GH) Gains NCCN Approval for Colorectal Cancer Test | GH Stock News - GuruFocus

08:53 AM
pulisher
08:42 AM

Guardant Health Announced the results of the Serena-6 Phase III Trial - marketscreener.com

08:42 AM
pulisher
08:15 AM

National Comprehensive Cancer Network (NCCN) Updates Colorectal Cancer Screening Guidelines to Include Shield Blood-Based Screening | GH Stock News - GuruFocus

08:15 AM
pulisher
08:12 AM

SERENA-6 Phase III Trial Demonstrates Clinical Value of Guardant360 CDx Test to Detect Emergence of Endocrine Resistance and Inform a Switch in Therapy Before Radiological Disease Progression in Advanced Breast Cancer - BioSpace

08:12 AM
pulisher
12:30 PM

Liquid Biopsy Market for Cancer Detection, cfDNA & CTC Analysis | - openPR.com

12:30 PM
pulisher
Jun 01, 2025

Guardant Health (GH) Reveals Key Insights on Colon Cancer Recurrence | GH Stock News - GuruFocus

Jun 01, 2025
pulisher
May 31, 2025

Guardant Health, Inc. (GH)’s ctDNA Test Predicts Colon Cancer Recurrence Risk in Stage III Patients - Insider Monkey

May 31, 2025
pulisher
May 31, 2025

In Largest Molecular Residual Disease (MRD) Study in Colon Cance - GuruFocus

May 31, 2025
pulisher
May 31, 2025

In Largest Molecular Residual Disease (MRD) Study in Colon Cancer, Guardant Reveal Testing Prior to Chemotherapy Provides Robust Stratification for Risk of Disease Recurrence and Survival to Enable Timely Treatment Decisions - Yahoo Finance

May 31, 2025
pulisher
May 31, 2025

Guardant Health, Inc. (GH) Expands Liquid Biopsy to Pinpoint Tumor Origins and Biomarkers - MSN

May 31, 2025
pulisher
May 30, 2025

Guardant Health Inc (GH) Stock Price Up 5.11% on May 30 - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Upcoming Chicago Meeting for Guardant Health (GH) Investors | GH Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

How Delfi Therapeutics plans to make liquid biopsies more accessible - The Business Journals

May 30, 2025
pulisher
May 28, 2025

Guardant Health Inc (GH) Trading Down 3.27% on May 28 - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Guardant Health, Inc. (NASDAQ:GH) Shares Sold by Nuveen Asset Management LLC - Defense World

May 28, 2025
pulisher
May 28, 2025

Guardant Health enhances cancer blood test capabilities By Investing.com - Investing.com South Africa

May 28, 2025
pulisher
May 28, 2025

Firing on All Cylinders: Guardant Health (NASDAQ:GH) Q1 Earnings Lead the Way - Yahoo Finance

May 28, 2025
pulisher
May 27, 2025

Guardant Health enhances cancer blood test capabilities - Investing.com Australia

May 27, 2025
pulisher
May 27, 2025

Guardant Health Introduces Nearly a Dozen Groundbreaking Smart Liquid Biopsy Applications for Guardant360 Liquid Test | GH Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Guardant Health Introduces Nearly a Dozen Groundbreaking Smart Liquid Biopsy Applications for Guardant360 Liquid Test - Eagle-Tribune

May 27, 2025
pulisher
May 25, 2025

Ameriprise Financial Inc. Purchases 76,124 Shares of Guardant Health, Inc. (NASDAQ:GH) - Defense World

May 25, 2025
pulisher
May 23, 2025

New Tests Promise to Reveal the Secrets in Your Blood - WSJ

May 23, 2025
pulisher
May 23, 2025

Investor Attention Turns to Biotech as Traditional Cancer Research Models Strain - Baystreet.ca

May 23, 2025
pulisher
May 23, 2025

Guardant Health and Collaborators to Present Over 19 Studies Demonstrating Role of Liquid Biopsy in Advancing Precision Oncology at 2025 ASCO Annual Meeting - BioSpace

May 23, 2025
pulisher
May 22, 2025

(GH) Technical Data - news.stocktradersdaily.com

May 22, 2025
pulisher
May 22, 2025

Guardant Health and Collaborators to Present Over 19 Studies Demonstrating Role of Liquid Biopsy in Advancing Precision Oncology at 2025 ASCO Annual Meeting | GH Stock News - GuruFocus

May 22, 2025
pulisher
May 21, 2025

Guardant Health, Evolent Health, Charles River Laboratories, Avantor, and Lumen Stocks Trade Down, What You Need To Know - Yahoo Finance

May 21, 2025
pulisher
May 21, 2025

Guardant Health (GH) introduces IHC Solid Tumor Testing to its Portfolio - Insider Monkey

May 21, 2025
pulisher
May 21, 2025

Guardant Health Launches Immunohistochemistry Testing for Solid Tumors - marketscreener.com

May 21, 2025
pulisher
May 21, 2025

Guardant Health Introduces Comprehensive Immunohistochemistry Testing for Solid Tumors - BioSpace

May 21, 2025
pulisher
May 21, 2025

Guardant Health, Inc. Introduces Comprehensive Immunohistochemistry Testing for Solid Tumors - marketscreener.com

May 21, 2025
pulisher
May 21, 2025

Guardant Health Introduces Comprehensive Immunohistochemistry Testing for Solid Tumors | GH Stock News - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Guardant Health expands oncology testing with IHC suite - Investing.com

May 21, 2025
pulisher
May 20, 2025

Guardant Health unveils new cancer risk test By Investing.com - Investing.com South Africa

May 20, 2025
pulisher
May 20, 2025

Guardant Health Introduces Hereditary Cancer Testing to Identify Inherited Predispositions to Certain Types of Cancer - BioSpace

May 20, 2025
pulisher
May 20, 2025

Guardant Health Introduces Hereditary Cancer Testing to Identify Inherited Predispositions to Certain Types of Cancer | GH Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Guardant Health unveils new cancer risk test - Investing.com

May 20, 2025
pulisher
May 16, 2025

Guardant Health: A Promising Player in the Liquid Biopsy Market - The Globe and Mail

May 16, 2025
pulisher
May 16, 2025

Guardant Health: A Promising Player In The Liquid Biopsy Market - Barchart.com

May 16, 2025
pulisher
May 16, 2025

New Horizons in Cancer Genetic Profiling Market Exploring - openPR.com

May 16, 2025

Guardant Health Inc (GH) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Guardant Health Inc (GH) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Tariq Musa
Director
May 15 '25
Option Exercise
0.00
250
0
3,595
POTTER MYRTLE S
Director
May 15 '25
Option Exercise
0.00
68
0
14,063
EAGLE CRAIG
Chief Medical Officer
May 15 '25
Option Exercise
0.00
3,718
0
36,318
Chudova Darya
Chief Technology Officer
May 15 '25
Option Exercise
0.00
8,705
0
83,210
diagnostics_research DGX
$174.50
price up icon 0.81%
diagnostics_research WAT
$343.98
price down icon 1.51%
diagnostics_research LH
$246.59
price down icon 1.03%
$158.47
price up icon 0.52%
diagnostics_research MTD
$1,138.41
price down icon 1.54%
diagnostics_research IQV
$139.15
price down icon 0.86%
大文字化:     |  ボリューム (24 時間):